Curcumin, an Inhibitor of PAK1, Potential Treatment for COVID-19

  • Nemati M
  • Asl E
  • Pouya F
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

… So, we can conclude that curcumin with anti-inflammatory properties and inhibition of PAK1, AP1 and NF-κB that create an inflammation status could be a potentially beneficial treatment …

Cite

CITATION STYLE

APA

Nemati, M., Asl, E., Pouya, F., & Rasmi, Y. (2020). Curcumin, an Inhibitor of PAK1, Potential Treatment for COVID-19. Journal of Infectiology, 3(2), 1–3. https://doi.org/10.29245/2689-9981/2020/2.1160

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free